Synthesis and antidepressant and anxiolytic activity of derivatives of pyrazolo[4,3-c]pyridine and 4-phenylhydrazinonicotinic acids

The synthesis of compounds effective in the treatment of anxiety—depression disorders is described. It is established that 4,6-dimethyl-2-(4-chlorophenyl)-2,3-dihydro-1 H -pyrazolo[4,3- c ]pyridine-3-one hydrochloride ( IVa ) possesses combined antidepressant and anxiolytic properties. Advantages of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pharmaceutical chemistry journal 2012-04, Vol.46 (1), p.15-19
Hauptverfasser: Zhmurenko, L. A., Molodavkin, G. M., Voronina, T. A., Lezina, V. P.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 19
container_issue 1
container_start_page 15
container_title Pharmaceutical chemistry journal
container_volume 46
creator Zhmurenko, L. A.
Molodavkin, G. M.
Voronina, T. A.
Lezina, V. P.
description The synthesis of compounds effective in the treatment of anxiety—depression disorders is described. It is established that 4,6-dimethyl-2-(4-chlorophenyl)-2,3-dihydro-1 H -pyrazolo[4,3- c ]pyridine-3-one hydrochloride ( IVa ) possesses combined antidepressant and anxiolytic properties. Advantages of IVa are low toxicity and the absence of side effects typical of antidepressants (elevated anxiety) and benzodiazepine anxiolytics (myorelaxant and sedative action).
doi_str_mv 10.1007/s11094-012-0726-z
format Article
fullrecord <record><control><sourceid>gale_cross</sourceid><recordid>TN_cdi_gale_infotracmisc_A359334756</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A359334756</galeid><sourcerecordid>A359334756</sourcerecordid><originalsourceid>FETCH-LOGICAL-c524t-78fe7b722899ef313743c1d5d2a81a1c0f8102f2d907d59cbe18394f5fd1ef443</originalsourceid><addsrcrecordid>eNp9kU9rXCEUxaW00GnaD9DdQLc18aovPpch9B8EsmgLhVLE6DVzwxsd9DX0zbZfvE4mm0IpInou53dQDmOvQZyCEOasAQiruQDJhZHnfP-ErWAwiluh4ClbCWGBwyC-PWcvWrsTolNKrtjvz0ueN9iorX2Ofc8UcVextX59HP2iMi0zhbUPM93TvKxLWkesdO-7xnaQu6X6fZnKd_1W8fCjS4qU8SFB890G8zJtlthNlEumUGbKD4kU20v2LPmp4avH84R9ff_uy-VHfnX94dPlxRUPg9QzN2NCc2OkHK3FpEAZrQLEIUo_gocg0ghCJhmtMHGw4QZhVFanIUXApLU6YW-Oubd-Qkc5lbn6sKUW3IUarFLaDOfddfoPV18Rt_3dGRP1-V8AHIFQS2sVk9tV2vq6OBDuUI47luN6Oe5Qjtt3Rh6Z1r35Fqu7Kz9r7r__D_QH70OU2g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Synthesis and antidepressant and anxiolytic activity of derivatives of pyrazolo[4,3-c]pyridine and 4-phenylhydrazinonicotinic acids</title><source>SpringerNature Journals</source><creator>Zhmurenko, L. A. ; Molodavkin, G. M. ; Voronina, T. A. ; Lezina, V. P.</creator><creatorcontrib>Zhmurenko, L. A. ; Molodavkin, G. M. ; Voronina, T. A. ; Lezina, V. P.</creatorcontrib><description>The synthesis of compounds effective in the treatment of anxiety—depression disorders is described. It is established that 4,6-dimethyl-2-(4-chlorophenyl)-2,3-dihydro-1 H -pyrazolo[4,3- c ]pyridine-3-one hydrochloride ( IVa ) possesses combined antidepressant and anxiolytic properties. Advantages of IVa are low toxicity and the absence of side effects typical of antidepressants (elevated anxiety) and benzodiazepine anxiolytics (myorelaxant and sedative action).</description><identifier>ISSN: 0091-150X</identifier><identifier>EISSN: 1573-9031</identifier><identifier>DOI: 10.1007/s11094-012-0726-z</identifier><language>eng</language><publisher>Boston: Springer US</publisher><subject>Alkaloids ; Antianxiety agents ; Antidepressants ; Depression, Mental ; Esters ; Medicine ; Organic Chemistry ; Pharmacology/Toxicology ; Pharmacy ; Pyridine</subject><ispartof>Pharmaceutical chemistry journal, 2012-04, Vol.46 (1), p.15-19</ispartof><rights>Springer Science+Business Media, Inc. 2012</rights><rights>COPYRIGHT 2012 Springer</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c524t-78fe7b722899ef313743c1d5d2a81a1c0f8102f2d907d59cbe18394f5fd1ef443</citedby><cites>FETCH-LOGICAL-c524t-78fe7b722899ef313743c1d5d2a81a1c0f8102f2d907d59cbe18394f5fd1ef443</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11094-012-0726-z$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11094-012-0726-z$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids></links><search><creatorcontrib>Zhmurenko, L. A.</creatorcontrib><creatorcontrib>Molodavkin, G. M.</creatorcontrib><creatorcontrib>Voronina, T. A.</creatorcontrib><creatorcontrib>Lezina, V. P.</creatorcontrib><title>Synthesis and antidepressant and anxiolytic activity of derivatives of pyrazolo[4,3-c]pyridine and 4-phenylhydrazinonicotinic acids</title><title>Pharmaceutical chemistry journal</title><addtitle>Pharm Chem J</addtitle><description>The synthesis of compounds effective in the treatment of anxiety—depression disorders is described. It is established that 4,6-dimethyl-2-(4-chlorophenyl)-2,3-dihydro-1 H -pyrazolo[4,3- c ]pyridine-3-one hydrochloride ( IVa ) possesses combined antidepressant and anxiolytic properties. Advantages of IVa are low toxicity and the absence of side effects typical of antidepressants (elevated anxiety) and benzodiazepine anxiolytics (myorelaxant and sedative action).</description><subject>Alkaloids</subject><subject>Antianxiety agents</subject><subject>Antidepressants</subject><subject>Depression, Mental</subject><subject>Esters</subject><subject>Medicine</subject><subject>Organic Chemistry</subject><subject>Pharmacology/Toxicology</subject><subject>Pharmacy</subject><subject>Pyridine</subject><issn>0091-150X</issn><issn>1573-9031</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNp9kU9rXCEUxaW00GnaD9DdQLc18aovPpch9B8EsmgLhVLE6DVzwxsd9DX0zbZfvE4mm0IpInou53dQDmOvQZyCEOasAQiruQDJhZHnfP-ErWAwiluh4ClbCWGBwyC-PWcvWrsTolNKrtjvz0ueN9iorX2Ofc8UcVextX59HP2iMi0zhbUPM93TvKxLWkesdO-7xnaQu6X6fZnKd_1W8fCjS4qU8SFB890G8zJtlthNlEumUGbKD4kU20v2LPmp4avH84R9ff_uy-VHfnX94dPlxRUPg9QzN2NCc2OkHK3FpEAZrQLEIUo_gocg0ghCJhmtMHGw4QZhVFanIUXApLU6YW-Oubd-Qkc5lbn6sKUW3IUarFLaDOfddfoPV18Rt_3dGRP1-V8AHIFQS2sVk9tV2vq6OBDuUI47luN6Oe5Qjtt3Rh6Z1r35Fqu7Kz9r7r__D_QH70OU2g</recordid><startdate>20120401</startdate><enddate>20120401</enddate><creator>Zhmurenko, L. A.</creator><creator>Molodavkin, G. M.</creator><creator>Voronina, T. A.</creator><creator>Lezina, V. P.</creator><general>Springer US</general><general>Springer</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20120401</creationdate><title>Synthesis and antidepressant and anxiolytic activity of derivatives of pyrazolo[4,3-c]pyridine and 4-phenylhydrazinonicotinic acids</title><author>Zhmurenko, L. A. ; Molodavkin, G. M. ; Voronina, T. A. ; Lezina, V. P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c524t-78fe7b722899ef313743c1d5d2a81a1c0f8102f2d907d59cbe18394f5fd1ef443</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Alkaloids</topic><topic>Antianxiety agents</topic><topic>Antidepressants</topic><topic>Depression, Mental</topic><topic>Esters</topic><topic>Medicine</topic><topic>Organic Chemistry</topic><topic>Pharmacology/Toxicology</topic><topic>Pharmacy</topic><topic>Pyridine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhmurenko, L. A.</creatorcontrib><creatorcontrib>Molodavkin, G. M.</creatorcontrib><creatorcontrib>Voronina, T. A.</creatorcontrib><creatorcontrib>Lezina, V. P.</creatorcontrib><collection>CrossRef</collection><jtitle>Pharmaceutical chemistry journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhmurenko, L. A.</au><au>Molodavkin, G. M.</au><au>Voronina, T. A.</au><au>Lezina, V. P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis and antidepressant and anxiolytic activity of derivatives of pyrazolo[4,3-c]pyridine and 4-phenylhydrazinonicotinic acids</atitle><jtitle>Pharmaceutical chemistry journal</jtitle><stitle>Pharm Chem J</stitle><date>2012-04-01</date><risdate>2012</risdate><volume>46</volume><issue>1</issue><spage>15</spage><epage>19</epage><pages>15-19</pages><issn>0091-150X</issn><eissn>1573-9031</eissn><abstract>The synthesis of compounds effective in the treatment of anxiety—depression disorders is described. It is established that 4,6-dimethyl-2-(4-chlorophenyl)-2,3-dihydro-1 H -pyrazolo[4,3- c ]pyridine-3-one hydrochloride ( IVa ) possesses combined antidepressant and anxiolytic properties. Advantages of IVa are low toxicity and the absence of side effects typical of antidepressants (elevated anxiety) and benzodiazepine anxiolytics (myorelaxant and sedative action).</abstract><cop>Boston</cop><pub>Springer US</pub><doi>10.1007/s11094-012-0726-z</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0091-150X
ispartof Pharmaceutical chemistry journal, 2012-04, Vol.46 (1), p.15-19
issn 0091-150X
1573-9031
language eng
recordid cdi_gale_infotracmisc_A359334756
source SpringerNature Journals
subjects Alkaloids
Antianxiety agents
Antidepressants
Depression, Mental
Esters
Medicine
Organic Chemistry
Pharmacology/Toxicology
Pharmacy
Pyridine
title Synthesis and antidepressant and anxiolytic activity of derivatives of pyrazolo[4,3-c]pyridine and 4-phenylhydrazinonicotinic acids
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T19%3A17%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis%20and%20antidepressant%20and%20anxiolytic%20activity%20of%20derivatives%20of%20pyrazolo%5B4,3-c%5Dpyridine%20and%204-phenylhydrazinonicotinic%20acids&rft.jtitle=Pharmaceutical%20chemistry%20journal&rft.au=Zhmurenko,%20L.%20A.&rft.date=2012-04-01&rft.volume=46&rft.issue=1&rft.spage=15&rft.epage=19&rft.pages=15-19&rft.issn=0091-150X&rft.eissn=1573-9031&rft_id=info:doi/10.1007/s11094-012-0726-z&rft_dat=%3Cgale_cross%3EA359334756%3C/gale_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A359334756&rfr_iscdi=true